Review Article
The Stemness Phenotype Model
Table 3
Detection of CSCs in established prostate cancer cell lines.
| Cell line | Percentage | Method | Reference |
| Human prostate basal cell isolation (primary culture) | 1% | CD133+ cells | [33] | LNCaP | 0.04% | CD44+ CD24- | [34] | DU145 | 7–10% | CD44+ CD24- | [34] | Dul45 | 50.67 ± 6.7 | CD44+ cells | [35] | LAPC-4 | 0.847 ± 0.3 | CD44+ cells | [35] | LAPC-9 | 13.97 ± 3.2 | CD44+ cells | [35] | Primary cultures from 5 different patients | 0.3–1.6 | CD44+/21hi/CD133+ Cells | [36] | PC-3, PC3P, PC3MM2 | 0.2, 0.6, 0.7 | CD133high | [37] |
|
|